0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Other Articles |

PNEUMOCOCCIC PNEUMONIA OF TYPE XIV IN CHILDREN TREATED WITH SPECIFIC SERUM

JESSE G. M. BULLOWA, M.D.; MORRIS GLEICH, M.D.; JOSEPH J. COHEN, M.D.; CONSTANCE LEBAIR, M.S.
Am J Dis Child. 1940;59(1):84-93. doi:10.1001/archpedi.1940.01990120086008.
Text Size: A A A
Published online

Physicians who have seen prompt termination of pneumonia and reduction in deaths and complications induced by adequate doses of specific antipneumococcus serum are impressed by the value of this method of treatment. However, acceptance of this therapy for children has been slow because of alleged dangers and difficulties and because the mortality of the pneumonias is considerably less among children than among adults. Because of this skepticism, the alternation of specific serum therapy among children was continued at Harlem Hospital until statistical evidence of its value was available in an adequate series of cases. After the frequency of type XIV pneumonia in children was learned, therapeutic serum was prepared in horses by the Department of Health of New York city. The observations recorded here, which bring up to date observations previously reported elsewhere, have extended over ten years.

Therapeutic serum was administered when available, to alternate patients, even though the

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();